This paper is in the following e-collection/theme issue:

Non-randomized Protocols and Methods (ehealth) (568) Emotional, Social, Psychological Support for Cancer (194) Innovations and Technology in Cancer Care (423)

Published on in Vol 8, No 12 (2019): December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/14361, first published .
Defining the Supportive Care Needs and Psychological Morbidity of Patients With Functioning Versus Nonfunctioning Neuroendocrine Tumors: Protocol for a Phase 1 Trial of a Nurse-Led Online and Phone-Based Intervention

Defining the Supportive Care Needs and Psychological Morbidity of Patients With Functioning Versus Nonfunctioning Neuroendocrine Tumors: Protocol for a Phase 1 Trial of a Nurse-Led Online and Phone-Based Intervention

Defining the Supportive Care Needs and Psychological Morbidity of Patients With Functioning Versus Nonfunctioning Neuroendocrine Tumors: Protocol for a Phase 1 Trial of a Nurse-Led Online and Phone-Based Intervention

Authors of this article:

Lisa Guccione1, 2 Author Orcid Image ;   Karla Gough2 Author Orcid Image ;   Allison Drosdowsky2 Author Orcid Image ;   Krista Fisher1 Author Orcid Image ;   Timothy Price3 Author Orcid Image ;   Nick Pavlakis4 Author Orcid Image ;   Mustafa Khasraw4 Author Orcid Image ;   David Wyld5, 6 Author Orcid Image ;   David Ransom7 Author Orcid Image ;   Grace Kong8 Author Orcid Image ;   Megan Rogers9 Author Orcid Image ;   Simone Leyden10 Author Orcid Image ;   John Leyden10 Author Orcid Image ;   Michael Michael11 Author Orcid Image ;   Penelope Schofield1, 2, 12 Author Orcid Image
Article Authors Cited by (3) Tweetations (1) Metrics

Journals

  1. Kolarova T, Bouvier C. The Role of Patient Support Groups in Neuroendocrine Neoplasms. Current Oncology Reports 2021;23(5) View
  2. Guccione L, Gough K, Drosdowsky A, Price T, Pavlakis N, Wyld D, Ransom D, Michael M, Schofield P. The unmet supportive care needs, quality of life, and care experiences of patients with functioning and non-functioning Neuroendocrine tumours (NETs) at early diagnosis. Patient Education and Counseling 2022;105(1):212 View
  3. Guccione L, Gough K, Drosdowsky A, Price T, Pavlakis N, Wyld D, Ransom D, Michael M, Schofield P. The unmet information needs, quality of life, and care experiences of patients with neuroendocrine tumours (NETs) at follow-up: 6 months from diagnosis. Supportive Care in Cancer 2023;31(10) View